Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMC 2840347)

Published in Proc Natl Acad Sci U S A on January 28, 2010

Authors

Sophie Duchez1, Rada Amin, Nadine Cogné, Laurent Delpy, Christophe Sirac, Virginie Pascal, Blaise Corthésy, Michel Cogné

Author Affiliations

1: Laboratoire d'Immunologie, Université de Limoges, Centre National de la Recherche Scientifique Unité Mixte 6101, F-87025 Limoges, France.

Articles citing this

Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction. Kidney Int (2015) 1.51

Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol (2013) 1.19

Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med (2011) 1.09

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med (2012) 1.08

AID-induced remodeling of immunoglobulin genes and B cell fate. Oncotarget (2014) 1.02

The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model. Oncotarget (2014) 0.99

New insights into the pathogenesis of IgA nephropathy. Semin Immunopathol (2014) 0.96

Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory. Immunity (2016) 0.85

Germinal Center B Cell Dynamics. Immunity (2016) 0.82

Immunoglobulin A: A next generation of therapeutic antibodies? MAbs (2011) 0.81

Antibody repertoire diversification through VH gene replacement in mice cloned from an IgA plasma cell. Proc Natl Acad Sci U S A (2015) 0.79

IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy. J Am Soc Nephrol (2016) 0.77

Deletion of the α immunoglobulin chain membrane-anchoring region reduces but does not abolish IgA secretion. Immunology (2012) 0.76

Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response. Mucosal Immunol (2013) 0.76

Complete cis Exclusion upon Duplication of the Eμ Enhancer at the Immunoglobulin Heavy Chain Locus. Mol Cell Biol (2015) 0.76

Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes. Am J Physiol Renal Physiol (2016) 0.75

IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition. J Am Soc Nephrol (2016) 0.75

The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis. Oncotarget (2016) 0.75

Self-control for IgE production. Oncotarget (2015) 0.75

RNA Exosome and Non-coding RNA-Coupled Mechanisms in AID-Mediated Genomic Alterations. J Mol Biol (2017) 0.75

Articles cited by this

IgA production without mu or delta chain expression in developing B cells. Nat Immunol (2001) 3.26

Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity (1997) 3.07

The regulation of IgA class switching. Nat Rev Immunol (2008) 2.92

Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol (2002) 2.84

Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol (1997) 2.77

The structure and function of human IgA. Biochem J (1990) 2.65

Mechanisms of divergence and convergence of the human immunoglobulin alpha 1 and alpha 2 constant region gene sequences. Cell (1984) 2.59

The influence of transcriptional orientation on endogenous switch region function. Nat Immunol (2003) 2.38

Induction of secretory immunity and memory at mucosal surfaces. Vaccine (2006) 2.24

The B-cell antigen receptor of the five immunoglobulin classes. Nature (1991) 1.97

Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 1.94

Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science (1996) 1.88

Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med (2007) 1.82

IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med (2007) 1.75

A distinct signaling pathway used by the IgG-containing B cell antigen receptor. Science (2002) 1.71

The mu switch region tandem repeats are important, but not required, for antibody class switch recombination. J Exp Med (2001) 1.52

Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today (1999) 1.51

Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J Exp Med (1997) 1.46

Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol (2009) 1.46

IgD can largely substitute for loss of IgM function in B cells. Nature (1998) 1.36

The murine immunoglobulin alpha gene expresses multiple transcripts from a unique membrane exon. EMBO J (1983) 1.34

Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest (1999) 1.32

Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J Exp Med (1999) 1.31

Incomplete block of B cell development and immunoglobulin production in mice carrying the muMT mutation on the BALB/c background. Eur J Immunol (2002) 1.24

Immunoglobulin class-switch recombination in mice devoid of any S mu tandem repeat. Blood (2004) 1.14

Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp Med (2000) 1.04

Early occurrence of immunoglobulin isotype switching in human fetal liver. Mol Immunol (1991) 1.01

The mouse B-cell antigen receptor: definition and assembly of the core receptor of the five immunoglobulin isotypes. Immunol Rev (1993) 0.94

Gene deletions force nonsecretory alpha-chain disease plasma cells to produce membrane-form alpha-chain only. J Immunol (1990) 0.90

Switch recombination in normal IgA1+ B lymphocytes. Proc Natl Acad Sci U S A (1994) 0.89

Effector BCRs: inside information on IgG. Nat Immunol (2002) 0.84

Augmentation of signaling through BCR containing IgE but not that containing IgA due to lack of CD22-mediated signal regulation. J Immunol (2007) 0.83

Membrane isoforms of human immunoglobulins of the A1 and A2 isotypes: structural and functional study. Immunology (1997) 0.81

Articles by these authors

Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis (2002) 2.78

Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity (2002) 2.17

Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood (2010) 1.86

Flexible long-range loops in the VH gene region of the Igh locus facilitate the generation of a diverse antibody repertoire. Immunity (2013) 1.56

The IgH locus 3' regulatory region: pulling the strings from behind. Adv Immunol (2011) 1.55

The IgH 3' regulatory region controls somatic hypermutation in germinal center B cells. J Exp Med (2013) 1.53

Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney. J Am Soc Nephrol (2005) 1.43

Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins. Trends Immunol (2003) 1.43

The beta-globin HS4 insulator confers copy-number dependent expression of IgH regulatory elements in stable B cell transfectants. Immunol Lett (2003) 1.41

17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J Immunol (2010) 1.40

Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol (2002) 1.39

The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol (2011) 1.38

The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J Immunol (2007) 1.37

Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region. Nature (2009) 1.34

Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J Immunol (2009) 1.31

Al amyloidosis. Orphanet J Rare Dis (2012) 1.29

Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment. J Immunol (2007) 1.26

Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation. J Immunol (2004) 1.21

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect Immun (2002) 1.20

Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53+/- mice and c-myc-3'RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin. Oncotarget (2012) 1.17

Ig synthesis and class switching do not require the presence of the hs4 enhancer in the 3' IgH regulatory region. J Immunol (2009) 1.15

Immunoglobulin class-switch recombination in mice devoid of any S mu tandem repeat. Blood (2004) 1.14

Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses. J Immunol (2005) 1.14

Glycans on secretory component participate in innate protection against mucosal pathogens. J Biol Chem (2006) 1.12

The immunoglobulin heavy-chain locus hs3b and hs4 3' enhancers are dispensable for VDJ assembly and somatic hypermutation. Blood (2003) 1.10

Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med (2011) 1.09

Microaerophilic conditions permit to mimic in vitro events occurring during in vivo Helicobacter pylori infection and to identify Rho/Ras-associated proteins in cellular signaling. J Biol Chem (2002) 1.08

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med (2012) 1.08

Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol (2011) 1.07

Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. J Immunol (2007) 1.06

Interallelic class switch recombination contributes significantly to class switching in mouse B cells. J Immunol (2005) 1.05

The IgH 3' regulatory region and its implication in lymphomagenesis. Eur J Immunol (2010) 1.05

Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b, and hs4) are dispensable for diversity of VDJ recombination. J Biol Chem (2012) 1.04

Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia. Am J Kidney Dis (2005) 1.03

B cell development arrest upon insertion of a neo gene between JH and Emu: promoter competition results in transcriptional silencing of germline JH and complete VDJ rearrangements. J Immunol (2002) 1.03

AID-induced remodeling of immunoglobulin genes and B cell fate. Oncotarget (2014) 1.02

Insulators to improve expression of a 3(')IgH LCR-driven reporter gene in transgenic mouse models. Biochem Biophys Res Commun (2003) 1.02

Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Adv Drug Deliv Rev (2013) 1.02

Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol (2004) 1.01

N-Glycans on secretory component: mediators of the interaction between secretory IgA and gram-positive commensals sustaining intestinal homeostasis. Gut Microbes (2011) 1.01

Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. Nephrol Dial Transplant (2010) 1.01

Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Contrib Nephrol (2011) 0.99

Elucidation of the enigmatic IgD class-switch recombination via germline deletion of the IgH 3' regulatory region. J Exp Med (2014) 0.99

A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice. Am J Pathol (2012) 0.99

In vivo redundant function of the 3' IgH regulatory element HS3b in the mouse. J Immunol (2010) 0.99

Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice. J Immunol (2013) 0.99

Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation (2009) 0.98

Recognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates. J Biol Chem (2011) 0.98

Solution structure of human secretory component and implications for biological function. J Biol Chem (2007) 0.98

Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production. J Immunol (2008) 0.97

AID-driven deletion causes immunoglobulin heavy chain locus suicide recombination in B cells. Science (2012) 0.96

Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells. PLoS Biol (2013) 0.95

Multiple RNA surveillance mechanisms cooperate to reduce the amount of nonfunctional Ig kappa transcripts. J Immunol (2010) 0.95

Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer (2010) 0.94

RNA surveillance down-regulates expression of nonfunctional kappa alleles and detects premature termination within the last kappa exon. Proc Natl Acad Sci U S A (2004) 0.94

Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae. Infect Immun (2007) 0.93

Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA. J Biol Chem (2010) 0.93

A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene. J Immunol (2011) 0.92

The role of secretory immunoglobulin A in the natural sensing of commensal bacteria by mouse Peyer's patch dendritic cells. J Biol Chem (2012) 0.92

Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias. J Leukoc Biol (2004) 0.92

Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. MBio (2011) 0.91

Germ-line transcription occurs on both the functional and the non-functional alleles of immunoglobulin constant heavy chain genes. Eur J Immunol (2003) 0.89

Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood (2006) 0.88

Food products and allergy development, prevention and treatment. Curr Opin Biotechnol (2006) 0.88

ABCA2 is a marker of neural progenitors and neuronal subsets in the adult rodent brain. J Neurochem (2006) 0.88

Transcription-dependent somatic hypermutation occurs at similar levels on functional and nonfunctional rearranged IgH alleles. J Immunol (2004) 0.88

Platelet activation after aortic prosthetic valve surgery. Interact Cardiovasc Thorac Surg (2005) 0.88

CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo. Blood (2006) 0.87

Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol (2007) 0.87

Simplified procedure to recover recombinant antigenized secretory IgA to be used as a vaccine vector. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.87

Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors. J Biol Chem (2009) 0.86

Cross talk between immunoglobulin heavy-chain transcription and RNA surveillance during B cell development. Mol Cell Biol (2011) 0.86

Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup. Haematologica (2005) 0.85

Increased B cell proliferation and reduced Ig production in DREAM transgenic mice. J Immunol (2010) 0.85

Differential expression of neurotensin and specific receptors, NTSR1 and NTSR2, in normal and malignant human B lymphocytes. J Immunol (2012) 0.85

Interallelic class switch recombination can reverse allelic exclusion and allow trans-complementation of an IgH locus switching defect. Eur J Immunol (2006) 0.85

Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect Immun (2013) 0.84

Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning. Infect Immun (2003) 0.83

Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS. Eur J Immunol (2010) 0.83

The polymorphism of the locus control region lying downstream the human IgH locus is restricted to hs1,2 but not to hs3 and hs4 enhancers. Immunol Lett (2004) 0.82

Glycotranscriptome study reveals an enzymatic switch modulating glycosaminoglycan synthesis during B-cell development and activation. Eur J Immunol (2011) 0.81

Light chain myeloma plasma cells induce a strong cell-mediated immune response mainly directed against the monoclonal light chain determinants in a murine experimental model. Cancer Immunol Immunother (2002) 0.81